GENERIC NAME | Bimatoprost 0.03% Soln. |
STRUCTURE | 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-N-ethyl-hept-5-enamide |
INDICATION'S | Ophthalmo.>Glaucoma>IOP |
OBSERVATION'S |
As Effective as Fixed Combi. of Latanoprost+Timo lol |
STATUS | USA Patent Expiration: 08.20.14 |
UPDATE | 12.11.07 |
COMPANY | Allergan |
PATENT NUMBER |
01 5,688,819. Allergan. DisClosure 02 6,933,289. Allergan. Irritation Redn. |
Want more information ? Interested in the hidden information ? Click here and do your request. |